<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Microba Life Sciences Limited — News on 6ix</title>
<link>https://6ix.com/company/microba-life-sciences-ltd</link>
<description>Latest news and press releases for Microba Life Sciences Limited on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 30 Apr 2026 03:38:34 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/microba-life-sciences-ltd" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683665f178dffbe2df15dbe4.webp</url>
<title>Microba Life Sciences Limited</title>
<link>https://6ix.com/company/microba-life-sciences-ltd</link>
</image>
<item>
<title>Q3 FY26 Quarterly Investor Presentation & Webinar</title>
<link>https://6ix.com/company/microba-life-sciences-ltd/news/q3-fy26-quarterly-investor-presentation-and-webinar</link>
<guid isPermaLink="true">https://6ix.com/company/microba-life-sciences-ltd/news/q3-fy26-quarterly-investor-presentation-and-webinar</guid>
<pubDate>Thu, 30 Apr 2026 03:38:34 GMT</pubDate>
<description>Q3 FY26 Quarterly Investor Presentation & Webinar</description>
</item>
<item>
<title>Appendix 4D & FY26 Interim Report</title>
<link>https://6ix.com/company/microba-life-sciences-ltd/news/appendix-4d-and-fy26-interim-report-2</link>
<guid isPermaLink="true">https://6ix.com/company/microba-life-sciences-ltd/news/appendix-4d-and-fy26-interim-report-2</guid>
<pubDate>Thu, 26 Feb 2026 03:26:08 GMT</pubDate>
<description>Appendix 4D & FY26 Interim Report</description>
</item>
<item>
<title>Q2 FY26 Quarterly Investor Presentation & Webinar</title>
<link>https://6ix.com/company/microba-life-sciences-ltd/news/q2-fy26-quarterly-investor-presentation-and-webinar</link>
<guid isPermaLink="true">https://6ix.com/company/microba-life-sciences-ltd/news/q2-fy26-quarterly-investor-presentation-and-webinar</guid>
<pubDate>Thu, 29 Jan 2026 03:44:21 GMT</pubDate>
<description>Q2 FY26 Quarterly Investor Presentation & Webinar</description>
</item>
<item>
<title>Q2 FY26 Quarterly Activities Report & Appendix 4C</title>
<link>https://6ix.com/company/microba-life-sciences-ltd/news/q2-fy26-quarterly-activities-report-and-appendix-4c-4</link>
<guid isPermaLink="true">https://6ix.com/company/microba-life-sciences-ltd/news/q2-fy26-quarterly-activities-report-and-appendix-4c-4</guid>
<pubDate>Thu, 29 Jan 2026 03:42:08 GMT</pubDate>
<description>Q2 FY26 Quarterly Activities Report & Appendix 4C</description>
</item>
<item>
<title>Microba receives $3 million R&D Tax Incentive Refund</title>
<link>https://6ix.com/company/microba-life-sciences-ltd/news/microba-receives-dollar3-million-randd-tax-incentive-refund</link>
<guid isPermaLink="true">https://6ix.com/company/microba-life-sciences-ltd/news/microba-receives-dollar3-million-randd-tax-incentive-refund</guid>
<pubDate>Wed, 03 Dec 2025 03:11:05 GMT</pubDate>
<description>Microba receives $3 million R&D Tax Incentive Refund</description>
</item>
<item>
<title>Q1 FY26 Quarterly Investor Presentation & Webinar</title>
<link>https://6ix.com/company/microba-life-sciences-ltd/news/q1-fy26-quarterly-investor-presentation-and-webinar</link>
<guid isPermaLink="true">https://6ix.com/company/microba-life-sciences-ltd/news/q1-fy26-quarterly-investor-presentation-and-webinar</guid>
<pubDate>Tue, 28 Oct 2025 02:42:20 GMT</pubDate>
<description>Q1 FY26 Quarterly Investor Presentation & Webinar</description>
</item>
<item>
<title>Q1 FY26 Quarterly Activities Report & Appendix 4C</title>
<link>https://6ix.com/company/microba-life-sciences-ltd/news/q1-fy26-quarterly-activities-report-and-appendix-4c-4</link>
<guid isPermaLink="true">https://6ix.com/company/microba-life-sciences-ltd/news/q1-fy26-quarterly-activities-report-and-appendix-4c-4</guid>
<pubDate>Tue, 28 Oct 2025 02:41:08 GMT</pubDate>
<description>Q1 FY26 Quarterly Activities Report & Appendix 4C</description>
</item>
<item>
<title>2025 Annual Report & Appendix 4E</title>
<link>https://6ix.com/company/microba-life-sciences-ltd/news/2025-annual-report-and-appendix-4e-4</link>
<guid isPermaLink="true">https://6ix.com/company/microba-life-sciences-ltd/news/2025-annual-report-and-appendix-4e-4</guid>
<pubDate>Tue, 26 Aug 2025 06:56:03 GMT</pubDate>
<description>2025 Annual Report & Appendix 4E</description>
</item>
<item>
<title>Q4 FY25 Quarterly Investor Presentation & Webinar</title>
<link>https://6ix.com/company/microba-life-sciences-ltd/news/q4-fy25-quarterly-investor-presentation-and-webinar</link>
<guid isPermaLink="true">https://6ix.com/company/microba-life-sciences-ltd/news/q4-fy25-quarterly-investor-presentation-and-webinar</guid>
<pubDate>Tue, 22 Jul 2025 03:19:31 GMT</pubDate>
<description>Q4 FY25 Quarterly Investor Presentation & Webinar</description>
</item>
<item>
<title>Q4 FY25 Quarterly Activities Report & Appendix 4C</title>
<link>https://6ix.com/company/microba-life-sciences-ltd/news/q4-fy25-quarterly-activities-report-and-appendix-4c-4</link>
<guid isPermaLink="true">https://6ix.com/company/microba-life-sciences-ltd/news/q4-fy25-quarterly-activities-report-and-appendix-4c-4</guid>
<pubDate>Tue, 22 Jul 2025 03:17:24 GMT</pubDate>
<description>Q4 FY25 Quarterly Activities Report & Appendix 4C</description>
</item>
<item>
<title>Disclosure Document - Prospectus</title>
<link>https://6ix.com/company/microba-life-sciences-ltd/news/disclosure-document-prospectus-1</link>
<guid isPermaLink="true">https://6ix.com/company/microba-life-sciences-ltd/news/disclosure-document-prospectus-1</guid>
<pubDate>Fri, 27 Jun 2025 05:58:20 GMT</pubDate>
<description>Disclosure Document - Prospectus</description>
</item>
<item>
<title>Reinstatement to Quotation</title>
<link>https://6ix.com/company/microba-life-sciences-ltd/news/reinstatement-to-quotation-120</link>
<guid isPermaLink="true">https://6ix.com/company/microba-life-sciences-ltd/news/reinstatement-to-quotation-120</guid>
<pubDate>Mon, 23 Jun 2025 06:56:03 GMT</pubDate>
<description>Reinstatement to Quotation</description>
</item>
<item>
<title>Strategic Investment & Equity Raise Presentation</title>
<link>https://6ix.com/company/microba-life-sciences-ltd/news/strategic-investment-and-equity-raise-presentation</link>
<guid isPermaLink="true">https://6ix.com/company/microba-life-sciences-ltd/news/strategic-investment-and-equity-raise-presentation</guid>
<pubDate>Mon, 23 Jun 2025 06:56:03 GMT</pubDate>
<description>Strategic Investment & Equity Raise Presentation</description>
</item>
<item>
<title>Microba secures $14.5 million to drive clinical adoption</title>
<link>https://6ix.com/company/microba-life-sciences-ltd/news/microba-secures-dollar145-million-to-drive-clinical-adoption</link>
<guid isPermaLink="true">https://6ix.com/company/microba-life-sciences-ltd/news/microba-secures-dollar145-million-to-drive-clinical-adoption</guid>
<pubDate>Mon, 23 Jun 2025 06:56:03 GMT</pubDate>
<description>Microba secures $14.5 million to drive clinical adoption</description>
</item>
<item>
<title>Suspension from Quotation</title>
<link>https://6ix.com/company/microba-life-sciences-ltd/news/suspension-from-quotation-136</link>
<guid isPermaLink="true">https://6ix.com/company/microba-life-sciences-ltd/news/suspension-from-quotation-136</guid>
<pubDate>Mon, 23 Jun 2025 05:17:10 GMT</pubDate>
<description>Suspension from Quotation</description>
</item>
<item>
<title>Trading Halt</title>
<link>https://6ix.com/company/microba-life-sciences-ltd/news/trading-halt-670</link>
<guid isPermaLink="true">https://6ix.com/company/microba-life-sciences-ltd/news/trading-halt-670</guid>
<pubDate>Thu, 19 Jun 2025 03:49:19 GMT</pubDate>
<description>Trading Halt</description>
</item>
<item>
<title>MetaPanel Pathogen Study Delivers Breakthrough Results</title>
<link>https://6ix.com/company/microba-life-sciences-ltd/news/metapanel-pathogen-study-delivers-breakthrough-results</link>
<guid isPermaLink="true">https://6ix.com/company/microba-life-sciences-ltd/news/metapanel-pathogen-study-delivers-breakthrough-results</guid>
<pubDate>Wed, 21 May 2025 03:33:13 GMT</pubDate>
<description>MetaPanel Pathogen Study Delivers Breakthrough Results</description>
</item>
<item>
<title>Microba Announces Landmark GI Study Results From Over 4,600 Patients</title>
<link>https://6ix.com/company/microba-life-sciences-ltd/news/microba-announces-landmark-gi-study-021200847</link>
<guid isPermaLink="true">https://6ix.com/company/microba-life-sciences-ltd/news/microba-announces-landmark-gi-study-021200847</guid>
<pubDate>Thu, 15 May 2025 02:12:00 GMT</pubDate>
<description>BRISBANE, Australia, May 15, 2025--Microba Life Sciences Limited (ASX: MAP) ("Microba" or the "Company"), a precision microbiome company, today announces preliminary results from the analysis of over 4,600 MetaXplore™ GI Plus test results, a comprehensive test for the assessment and management of lower gastrointestinal disorders, spanning symptoms including chronic pain, bloating, constipation, or diarrhea. This study demonstrates that MetaXplore can support clinicians to identify and address un</description>
</item>
<item>
<title>Landmark GI Study Results from over 4,600 patients</title>
<link>https://6ix.com/company/microba-life-sciences-ltd/news/landmark-gi-study-results-from-over-4600-patients</link>
<guid isPermaLink="true">https://6ix.com/company/microba-life-sciences-ltd/news/landmark-gi-study-results-from-over-4600-patients</guid>
<pubDate>Wed, 14 May 2025 03:23:15 GMT</pubDate>
<description>Landmark GI Study Results from over 4,600 patients</description>
</item>
<item>
<title>Q3 FY25 Quarterly Investor Presentation & Webinar</title>
<link>https://6ix.com/company/microba-life-sciences-ltd/news/q3-fy25-quarterly-investor-presentation-and-webinar</link>
<guid isPermaLink="true">https://6ix.com/company/microba-life-sciences-ltd/news/q3-fy25-quarterly-investor-presentation-and-webinar</guid>
<pubDate>Wed, 30 Apr 2025 03:44:27 GMT</pubDate>
<description>Q3 FY25 Quarterly Investor Presentation & Webinar</description>
</item>
</channel>
</rss>